Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

A small molecule inhibitor of Rheb selectively targets mTORC1 signaling

Journal Article · · Nature Communications
; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1499739
Journal Information:
Nature Communications, Vol. 9, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

References (67)

Rheb in neuronal degeneration, regeneration, and connectivity May 2017
The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling: ROLE IN FTI ENHANCEMENT OF TAXANE AND TAMOXIFEN ANTI-TUMOR ACTIVITY July 2005
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2 February 2011
Inhibition of Ras for cancer treatment: the search continues October 2011
The Ras superfamily at a glance March 2005
mTORC1 and the regulation of skeletal muscle anabolism and mass June 2012
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions November 2013
mTOR is a key modulator of ageing and age-related disease January 2013
New tricks for human farnesyltransferase inhibitor: cancer and beyond January 2017
The mTOR Pathway in the Control of Protein Synthesis October 2006
mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation June 2008
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway March 2016
Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases June 2012
KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1 February 2017
mTOR inhibitors in renal cell carcinoma July 2011
Therapeutic targeting of mTOR in tuberous sclerosis January 2009
First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014 March 2015
Recent progress in the study of the Rheb family GTPases September 2014
Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo September 2014
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB April 2006
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase March 2007
mTOR Signaling in Growth Control and Disease April 2012
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output June 2013
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity March 2012
The mTOR signalling cascade: paving new roads to cure neurological disease June 2016
mTOR Inhibition by Rapamycin Prevents  -Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes January 2008
Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts November 2013
mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation April 2015
Strategies for the management of adverse events associated with mTOR inhibitors July 2014
The Rheb Switch 2 Segment Is Critical for Signaling to Target of Rapamycin Complex 1 April 2007
NMR Spectroscopy Techniques for Screening and Identifying Ligand Binding to Protein Receptors February 2003
Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions August 2015
Drugging the undruggable RAS: Mission Possible? October 2014
Multivalent Small-Molecule Pan-RAS Inhibitors February 2017
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation October 2008
Ras Homolog Enriched in Brain (Rheb) Enhances Apoptotic Signaling August 2010
Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity November 2011
The mTOR Signalling Pathway in Human Cancer February 2012
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks December 2011
Structural Basis for the Unique Biological Function of Small GTPase RHEB February 2005
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study July 2012
mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin July 2013
Affinity selection-mass spectrometry screening techniques for small molecule drug discovery October 2007
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity October 2011
Rheb Is Essential for Murine Development February 2011
mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis September 2015
mTOR complex 2 signaling and functions July 2011
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies March 2016
Long-term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High-Fat Diet-fed KK/HlJ Mice September 2009
Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours June 2003
mTOR: from growth signal integration to cancer, diabetes and ageing December 2010
Small-molecule modulation of Ras signaling June 2014
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40 December 2017
Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin August 2016
Discovery and characterization of small molecules that target the GTPase Ral September 2014
Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation December 2013
Automated NMR Fragment Based Screening Identified a Novel Interface Blocker to the LARG/RhoA Complex February 2014
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma August 2012
Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner July 2003
Identification of Dominant Negative Mutants of Rheb GTPase and Their Use to Implicate the Involvement of Human Rheb in the Activation of p70S6K July 2003
The Sestrins Interact with GATOR2 to Negatively Regulate the Amino-Acid-Sensing Pathway Upstream of mTORC1 October 2014
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity March 2012
Diabetes after Transplantation and Sirolimus: What's the Connection? June 2008
Rapamycin: One Drug, Many Effects March 2014
Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells August 2013
Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways April 2004
Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice April 2017

Similar Records

Related Subjects